The role and importance of primary care physicians (general practitioners and internists) are increasingly recognized in the diagnosis and management of patients with obesity and non-alcoholic fatty liver disease (NAFLD). This article discusses a diagnostic algorithm for obesity based on the AACE/ACE-2014 classification and explores the therapeutic potential of essential phospholipids within preventive and treatment recommendations for patients with obesity-associated NAFLD.